ELBA: Exemestane and Lapatinib in Advanced Breast Cancer

NCT01005641 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study not started for administrative reasons

Conditions

Breast Cancer

Interventions

DRUG: exemestane
DRUG: lapatinib

Sponsor

National Cancer Institute, Naples